DV-Pharm Limited - Limited company - abbreviated - 11.6

DV-Pharm Limited - Limited company - abbreviated - 11.6


07034936 1.1.14 31.12.14 31.12.14 Company accounts Private Limited Company FY true false true false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure070349362013-12-31070349362014-12-31070349362014-01-012014-12-31070349362012-12-31070349362013-01-012013-12-31070349362013-12-3107034936ns12:England2014-01-012014-12-3107034936ns14:PoundSterling2014-01-012014-12-3107034936ns7:Director12014-01-012014-12-3107034936ns7:OrdinaryShareClass12014-01-012014-12-3107034936ns7:Director22014-01-012014-12-3107034936ns7:RegisteredOffice2014-01-012014-12-3107034936ns7:MainBusiness2014-01-012014-12-3107034936ns5:LandBuildingsns5:ShortLeaseholdProperties2014-01-012014-12-3107034936ns5:FixturesFittings2014-01-012014-12-3107034936ns7:OrdinaryShareClass12014-12-3107034936ns7:OrdinaryShareClass12013-12-31
REGISTERED NUMBER: 07034936 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 31 December 2014

for

Dv-pharm Limited

Dv-pharm Limited (Registered number: 07034936)






Contents of the Abbreviated Accounts
for the Year Ended 31 December 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Dv-pharm Limited

Company Information
for the Year Ended 31 December 2014







DIRECTORS: Mr Vinay Mehta
Mr Dipak Vanechand Mehta





REGISTERED OFFICE: Devonshire House
582 Honeypot Lane
Stanmore
Middlesex
HA7 1JS





BUSINESS ADDRESS: 185 Muswell Hill Broadway
Muswell Hill
London
N10 3RS





REGISTERED NUMBER: 07034936 (England and Wales)

Dv-pharm Limited (Registered number: 07034936)

Abbreviated Balance Sheet
31 December 2014

31.12.14 31.12.13
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 2 71,330 76,086
Tangible assets 3 24,695 29,178
96,025 105,264

CURRENT ASSETS
Stocks 87,032 65,677
Debtors 4 31,692 72,175
Prepayments and accrued income 63,792 -
Cash at bank and in hand 130,282 92,877
312,798 230,729
CREDITORS
Amounts falling due within one year 111,832 103,169
NET CURRENT ASSETS 200,966 127,560
TOTAL ASSETS LESS CURRENT
LIABILITIES

296,991

232,824

CREDITORS
Amounts falling due after more than one
year

(99,982
)
(99,982
)

PROVISIONS FOR LIABILITIES (4,939 ) (5,836 )
NET ASSETS 192,070 127,006

CAPITAL AND RESERVES
Called up share capital 5 2 2
Profit and loss account 192,068 127,004
SHAREHOLDERS' FUNDS 192,070 127,006

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

Dv-pharm Limited (Registered number: 07034936)

Abbreviated Balance Sheet - continued
31 December 2014


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 18 September 2015 and were signed on its behalf
by:





Mr Dipak Vanechand Mehta - Director


Dv-pharm Limited (Registered number: 07034936)

Notes to the Abbreviated Accounts
for the Year Ended 31 December 2014

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Short leasehold - in accordance with the property
Fixtures and fittings - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

2. INTANGIBLE FIXED ASSETS
Total
£   
COST
At 1 January 2014
and 31 December 2014 95,110
AMORTISATION
At 1 January 2014 19,024
Amortisation for year 4,756
At 31 December 2014 23,780
NET BOOK VALUE

At 31 December 2014 71,330
At 31 December 2013 76,086

Dv-pharm Limited (Registered number: 07034936)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 December 2014

3. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 January 2014
and 31 December 2014 48,819
DEPRECIATION
At 1 January 2014 19,641
Charge for year 4,483
At 31 December 2014 24,124
NET BOOK VALUE
At 31 December 2014 24,695
At 31 December 2013 29,178

4. DEBTORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

The aggregate total of debtors falling due after more than one year is £ 29,000 (31.12.13 - £ 29,000 )

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.14 31.12.13
value: £    £   
2 Ordinary Shares £1 2 2